Transfusion for anemia
Pro Research Analysisby 
Searched over 200M research papers
Transfusion for Anemia: A Comprehensive Overview
Immediate Transfusion in African Children with Severe Anemia
The World Health Organization (WHO) advises against immediate transfusions for African children hospitalized with uncomplicated severe anemia (hemoglobin levels of 4 to 6 g/dL) unless clinical severity signs are present. However, a study involving Ugandan and Malawian children aged 2 months to 12 years explored the outcomes of immediate transfusion versus a triggered transfusion strategy. The study found no significant differences in 28-day and 180-day mortality rates between the immediate-transfusion group and the control group, although the control group required longer hospital stays and more clinical monitoring1.
Transfusions for Anemia in Patients with Malignancies
Anemia is prevalent in over two-thirds of patients with malignant hematological disorders. The causes include ineffective erythropoiesis, marrow infiltration, cytokine suppression, and vitamin deficiencies. Conservative transfusion practices have shown equivalent outcomes to liberal practices, with benefits such as reduced in-hospital mortality and fewer cardiac events. Alternative treatments like intravenous iron and erythropoietin-stimulating agents (ESAs) are also recommended in appropriate settings2.
Transfusion Thresholds in Different Patient Groups
Historically, RBC transfusions were guided by maintaining hemoglobin levels above 100 g/L. Modern guidelines, informed by numerous randomized controlled trials and systematic reviews, now support more restrictive transfusion thresholds. These thresholds vary across clinical settings, including intensive care, cardiovascular surgery, and pediatric populations. Restrictive transfusion strategies have generally shown to be as effective as liberal strategies, with fewer associated risks3.
Anemia and Transfusion in Neurocritical Care
Anemia is common in critically ill patients, including those with brain injuries. While restrictive transfusion practices are generally safe, severe anemia (hemoglobin <7 g/dL) may be harmful in neurocritical care patients due to the risk of secondary cerebral injury. Observational studies suggest that lower hemoglobin levels correlate with worse outcomes, but more aggressive transfusion does not necessarily improve these outcomes. Further research is needed to establish optimal transfusion thresholds in this population4.
Blood Transfusions in Advanced Cancer Patients
Anemia affects a significant proportion of patients with advanced cancer, yet only a minority receive transfusions. A systematic review found that transfusions provided a subjective improvement in symptoms like fatigue and breathlessness, but the benefits often waned by day 14 post-transfusion. High mortality rates within two weeks of transfusion highlight the need for better criteria to identify patients who would benefit most from transfusions5.
Anemia and Transfusions in Preterm Infants
Preterm infants in the NICU often suffer from anemia, which can lead to hypoxic tissue injury, including brain damage. RBC transfusions can improve cerebral oxygenation and support brain development. However, restrictive transfusion strategies have been associated with better long-term neurodevelopmental outcomes. Individualized care focusing on cerebral oxygen saturation is recommended to optimize both short-term and long-term outcomes6.
Anemia and Transfusion in Critical Care
In critically ill patients, anemia is generally well-tolerated if oxygen delivery remains adequate. The risks of transfusion, including immune modulation and infection, necessitate a careful balance between benefits and risks. Restrictive transfusion practices are often preferred, except in cases like acute coronary syndromes where more liberal transfusion may be beneficial7 8.
Conclusion
Transfusion strategies for anemia vary significantly across different patient populations and clinical settings. While restrictive transfusion practices are generally supported by evidence, specific conditions such as neurocritical care and advanced cancer may require more nuanced approaches. Ongoing research and individualized patient care are essential to optimize outcomes and minimize risks associated with transfusions.
Sources and full results
Most relevant research papers on this topic
Immediate Transfusion in African Children with Uncomplicated Severe Anemia.
Immediate transfusion in African children with uncomplicated severe anemia did not show a difference in clinical outcomes over 6 months, but triggered transfusion strategies resulted in lower blood use but longer hospital stays.
RCT
Large Human Trial
Rigorous JournalTransfusions for anemia in adult and pediatric patients with malignancies
Conservative red blood cell transfusion practices in patients with malignancies can improve outcomes and reduce risks, while alternative management strategies like IV iron and erythropoietin stimulating agents may be appropriate.
Review of available evidence supporting different transfusion thresholds in different patient groups with anemia
Different anemia criteria based on Hb concentration can improve outcomes and quality of life in various clinical populations, but should be cautiously considered due to risks, economic costs, and limited blood supply.
Systematic ReviewRigorous JournalAnemia and red blood cell transfusion in neurocritical care
Severe anemia, as low as 7 g/dl, may be harmful in brain-injured patients, and randomized controlled trials are needed to optimize transfusion thresholds in neurocritical care settings.
Systematic ReviewRigorous Journal
Highly CitedBlood transfusions for anaemia in patients with advanced cancer.
Blood transfusions for anaemia in advanced cancer patients show a 31% to 70% subjective response rate, but higher-quality studies are needed to determine their effectiveness and potential harms.
Systematic Review
Very Rigorous JournalAnemia and Red Blood Cell Transfusions, Cerebral Oxygenation, Brain Injury and Development, and Neurodevelopmental Outcome in Preterm Infants: A Systematic Review
Anemia and red blood cell transfusions in preterm infants are associated with cerebral oxygenation, brain injury, and neurodevelopmental outcomes.
Systematic ReviewAnemia and Transfusion in Critical Care
In critically ill patients, anemia should be managed to avoid oxygen supply dependency and maintain moderate oxygen delivery reserve, with cultured red cells potentially offering a safer option.
Literature ReviewRigorous JournalAnemia, allogenic blood transfusion, and immunomodulation in the critically ill.
Restrictive transfusion practices in critically ill patients may reduce morbidity and mortality, but may not be effective for acute coronary syndromes.
Highly CitedHow I Treat Anemia with Red Blood Cell Transfusion and Iron.
Red blood cell transfusion is safe and effective for treating severe anemia, but it's crucial to consider patient symptoms, preferences, and the etiology of the anemia.
Case ReportAnemia and perioperative red blood cell transfusion: a matter of tolerance.
Perioperative red blood cell transfusions should be avoided when possible due to adverse outcomes and should be limited to compensatory mechanisms during acute anemia.
Highly Cited